// AST – IMS - [DMinute_ROS]

Willingdon Wealth Management Has Trimmed Eog Res (EOG) Position By $1.65 Million; Zuckerman Investment Group Has Cut By $571,426 Its Ptc Therapeutics (PTCT) Stake

PTC Therapeutics, Inc. (NASDAQ:PTCT) Logo

Willingdon Wealth Management decreased Eog Res Inc (EOG) stake by 98.05% reported in 2018Q3 SEC filing. Willingdon Wealth Management sold 13,188 shares as Eog Res Inc (EOG)’s stock declined 11.03%. The Willingdon Wealth Management holds 262 shares with $33,000 value, down from 13,450 last quarter. Eog Res Inc now has $56.81B valuation. The stock increased 1.13% or $1.09 during the last trading session, reaching $97.96. About 951,532 shares traded. EOG Resources, Inc. (NYSE:EOG) has risen 2.00% since January 14, 2018 and is uptrending. It has outperformed by 2.00% the S&P500. Some Historical EOG News: 25/04/2018 – SSETS INCLUDE CONWY OILFIELD IN EAST IRISH SEA, STAKE IN COLUMBUS GAS PROJECT IN NORTH SEA -DOCUMENT; 27/03/2018 – EOG SAYS LOCKED IN 60% OF ITS OILFIELD SERVICES FOR 2018; 27/03/2018 – EOG RESOURCES INC EOG.N CHIEF EXECUTIVE BILL THOMAS SAYS HAS LOCKED IN 60 PCT OF OILFIELD SERVICE NEEDS FOR 2018; 03/05/2018 – EOG RESOURCES INC – TARGETS $3 BLN DEBT REDUCTION AND HIGHER DIVIDEND GROWTH RATE; 27/03/2018 – Ernest Scheyder: EOG Resources expects service costs in the Permian to drop 9 percent this year. (That’s because it; 22/05/2018 – EOG Resources at UBS Global Oil & Gas Conference Tomorrow; 03/05/2018 – EOG to Accelerate Dividend Growth as Shale Becomes Cash Machine; 03/05/2018 – EOG Resources: Maintained Forecast for 2018 Cap Expenditures of $5.4B-$5.8B; 04/05/2018 – EOG FAVORS INVESTMENT, DEBT REPAYMENT, DIVIDENDS OVER BUYBACKS; 21/05/2018 – EOG RESOURCES INC EOG.N : SIMMONS RAISES TARGET PRICE TO $138 FROM $123

Zuckerman Investment Group Llc decreased Ptc Therapeutics (PTCT) stake by 73.33% reported in 2018Q3 SEC filing. Zuckerman Investment Group Llc sold 12,158 shares as Ptc Therapeutics (PTCT)’s stock declined 26.52%. The Zuckerman Investment Group Llc holds 4,421 shares with $208,000 value, down from 16,579 last quarter. Ptc Therapeutics now has $1.77 billion valuation. The stock decreased 1.48% or $0.53 during the last trading session, reaching $35.17. About 149,411 shares traded. PTC Therapeutics, Inc. (NASDAQ:PTCT) has risen 106.09% since January 14, 2018 and is uptrending. It has outperformed by 106.09% the S&P500. Some Historical PTCT News: 24/05/2018 – 2018 Market Spotlight: Duchenne Muscular Dystrophy (DMD) – PTC Therapeutics Leads Industry Sponsors With the Highest Number of Clinical Trials, Followed by GlaxoSmithKline – ResearchAndMarkets.com; 28/03/2018 – PTC Therapeutics Announces Pricing of Public Offering of Common Stk; 29/05/2018 – D. E. SHAW REPORTS 5.0% PASSIVE STAKE IN PTC THERAPEUTICS; 27/03/2018 – PTC Therapeutics Announces Proposed Public Offering of Common Stk; 09/05/2018 – MK&A ACQUIRED BY FORMER PTC THERAPEUTICS PRESIDENT HIRAWAT; 12/04/2018 – PTC Therapeutics Announces Full Exercise of Underwriters’ Option to Purchase Additional Shrs; 09/05/2018 – PTC THERAPEUTICS INC QTRLY SHR LOSS $0.46; 15/05/2018 – Marshall Wace North America Buys 1.4% of PTC Therapeutics; 09/05/2018 – PTC Therapeutics 1Q Loss/Shr 46c; 30/04/2018 – PTC Therapeutics to Participate at Upcoming Investor Conference

Willingdon Wealth Management increased Chevron Corp New (NYSE:CVX) stake by 3,615 shares to 47,730 valued at $5.84 million in 2018Q3. It also upped Honeywell Intl Inc (NYSE:HON) stake by 1,862 shares and now owns 24,275 shares. Crown Castle Intl Corp New (Prn) (NYSE:CCI) was raised too.

Another recent and important EOG Resources, Inc. (NYSE:EOG) news was published by Seekingalpha.com which published an article titled: “EOG Resources Operates Comfortably At $40 Oil – Seeking Alpha” on November 27, 2018.

Among 11 analysts covering EOG Resources (NYSE:EOG), 9 have Buy rating, 0 Sell and 2 Hold. Therefore 82% are positive. EOG Resources had 18 analyst reports since July 24, 2018 according to SRatingsIntel. The rating was maintained by Stifel Nicolaus on Friday, August 3 with “Buy”. Morgan Stanley maintained EOG Resources, Inc. (NYSE:EOG) on Wednesday, September 26 with “Equal-Weight” rating. The stock of EOG Resources, Inc. (NYSE:EOG) earned “Outperform” rating by Credit Suisse on Friday, November 16. Morgan Stanley maintained the stock with “Equal-Weight” rating in Monday, November 5 report. The firm earned “Outperform” rating on Tuesday, November 6 by Raymond James. The company was maintained on Thursday, August 16 by Morgan Stanley. JP Morgan upgraded it to “Overweight” rating and $118 target in Friday, December 7 report. Wells Fargo maintained EOG Resources, Inc. (NYSE:EOG) on Wednesday, October 24 with “Market Perform” rating. The stock of EOG Resources, Inc. (NYSE:EOG) earned “Equal-Weight” rating by Morgan Stanley on Friday, October 12. Morgan Stanley maintained EOG Resources, Inc. (NYSE:EOG) rating on Tuesday, November 20. Morgan Stanley has “Equal-Weight” rating and $118 target.

Investors sentiment increased to 1.23 in 2018 Q3. Its up 0.18, from 1.05 in 2018Q2. It improved, as 35 investors sold EOG shares while 288 reduced holdings. 96 funds opened positions while 301 raised stakes. 479.51 million shares or 0.90% less from 483.89 million shares in 2018Q2 were reported. The Massachusetts-based Welch And Forbes Llc has invested 0.21% in EOG Resources, Inc. (NYSE:EOG). Piedmont Inv Advsr Incorporated stated it has 0.06% in EOG Resources, Inc. (NYSE:EOG). 154 were accumulated by Adirondack Trust. Sumitomo Mitsui Asset holds 0.11% or 55,917 shares. 18,772 were accumulated by Marshall Wace Llp. First Hawaiian National Bank & Trust holds 0.07% or 11,185 shares in its portfolio. Nelson Van Denburg Campbell Wealth Mngmt Gru Ltd invested in 0.07% or 2,487 shares. Wg Shaheen And Assoc Dba Whitney And Company has invested 0% in EOG Resources, Inc. (NYSE:EOG). Farmers Merchants Invs Incorporated has 224 shares for 0% of their portfolio. Alleghany De has 615,000 shares for 1.88% of their portfolio. The Massachusetts-based Natixis Advsr LP has invested 0.11% in EOG Resources, Inc. (NYSE:EOG). Zwj Inv Counsel holds 21,414 shares or 0.22% of its portfolio. Lmr Partners Llp owns 14,594 shares. Wetherby Asset Mgmt has 0.17% invested in EOG Resources, Inc. (NYSE:EOG) for 10,780 shares. State Street Corporation has invested 0.27% in EOG Resources, Inc. (NYSE:EOG).

Analysts await EOG Resources, Inc. (NYSE:EOG) to report earnings on February, 26. They expect $1.55 EPS, up 124.64% or $0.86 from last year’s $0.69 per share. EOG’s profit will be $898.84M for 15.80 P/E if the $1.55 EPS becomes a reality. After $1.75 actual EPS reported by EOG Resources, Inc. for the previous quarter, Wall Street now forecasts -11.43% negative EPS growth.

Since September 11, 2018, it had 0 insider buys, and 4 selling transactions for $1.05 million activity. Shares for $209,309 were sold by CRISP CHARLES R on Tuesday, September 11. 2,489 EOG Resources, Inc. (NYSE:EOG) shares with value of $317,203 were sold by Trice David W. The insider Yacob Ezra Y sold $235,851. 3,150 EOG Resources, Inc. (NYSE:EOG) shares with value of $291,679 were sold by WISNER FRANK G.

Among 6 analysts covering PTC Therapeutics (NASDAQ:PTCT), 4 have Buy rating, 1 Sell and 1 Hold. Therefore 67% are positive. PTC Therapeutics had 9 analyst reports since July 19, 2018 according to SRatingsIntel. The firm has “Equal-Weight” rating by Barclays Capital given on Wednesday, August 8. As per Tuesday, July 31, the company rating was maintained by Bank of America. RBC Capital Markets maintained the stock with “Outperform” rating in Tuesday, November 6 report. The firm has “Equal-Weight” rating by Barclays Capital given on Tuesday, November 6. As per Monday, November 12, the company rating was maintained by Cantor Fitzgerald. The company was maintained on Wednesday, September 5 by Credit Suisse. Citigroup maintained PTC Therapeutics, Inc. (NASDAQ:PTCT) rating on Tuesday, July 24. Citigroup has “Buy” rating and $50 target.

Investors sentiment decreased to 1.17 in 2018 Q3. Its down 0.60, from 1.77 in 2018Q2. It is negative, as 21 investors sold PTCT shares while 48 reduced holdings. 41 funds opened positions while 40 raised stakes. 42.98 million shares or 11.98% more from 38.38 million shares in 2018Q2 were reported. Mak Capital One Limited Liability Co stated it has 3.41% of its portfolio in PTC Therapeutics, Inc. (NASDAQ:PTCT). Virginia Retirement Et Al accumulated 20,600 shares or 0.01% of the stock. Aqr Capital Llc reported 45,104 shares or 0% of all its holdings. Massachusetts-based Adage Capital Partners Group Ltd Llc has invested 0.01% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Moreover, Daiwa Securities Group has 0% invested in PTC Therapeutics, Inc. (NASDAQ:PTCT). Sectoral Asset holds 1.02% or 204,237 shares in its portfolio. Ghost Tree Lc holds 5.01% or 500,000 shares in its portfolio. 19,367 are owned by Perceptive Advsrs Limited Liability Company. Rothschild & Asset Mngmt Us accumulated 28,253 shares. Kepos Capital Lp has invested 0.08% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Moore LP stated it has 0.1% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Element Cap Mgmt Limited has invested 0.01% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Rhumbline Advisers has invested 0% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Oppenheimer stated it has 0.02% in PTC Therapeutics, Inc. (NASDAQ:PTCT). Massachusetts-based Bogle Invest Mngmt LP De has invested 0.65% in PTC Therapeutics, Inc. (NASDAQ:PTCT).

More notable recent PTC Therapeutics, Inc. (NASDAQ:PTCT) news were published by: Prnewswire.com which released: “PTC Therapeutics Announces Executive Team Updates Focused on Accelerating Pipeline and Bringing Gene Therapy Manufacturing In-house – PRNewswire” on January 07, 2019, also Seekingalpha.com with their article: “EMA grants Prime status for Roche’s risdiplam for SMA – Seeking Alpha” published on December 17, 2018, Nasdaq.com published: “Options Traders Expect Huge Moves in PTC Therapeutics (PTCT) Stock – Nasdaq” on July 19, 2018. More interesting news about PTC Therapeutics, Inc. (NASDAQ:PTCT) were released by: Nasdaq.com and their article: “Should You Invest in the Invesco DWA Healthcare Momentum ETF (PTH)? – Nasdaq” published on December 17, 2018 as well as Nasdaq.com‘s news article titled: “February 22nd Options Now Available For PTC Therapeutics (PTCT) – Nasdaq” with publication date: January 03, 2019.

Since January 7, 2019, it had 0 buys, and 4 insider sales for $123,189 activity. $22,692 worth of PTC Therapeutics, Inc. (NASDAQ:PTCT) shares were sold by Almstead Neil Gregory. Another trade for 2,512 shares valued at $87,292 was sold by Peltz Stuart Walter. Utter Christine Marie also sold $10,321 worth of PTC Therapeutics, Inc. (NASDAQ:PTCT) on Monday, January 7. Souza Marcio sold $2,884 worth of PTC Therapeutics, Inc. (NASDAQ:PTCT) on Monday, January 7.

Zuckerman Investment Group Llc increased Stericycle Inc. (NASDAQ:SRCL) stake by 9,905 shares to 114,000 valued at $6.69 million in 2018Q3. It also upped Spartan Motors Inc. (NASDAQ:SPAR) stake by 163,476 shares and now owns 522,481 shares. Hamilton Beach Brand Hldg C was raised too.

Analysts await PTC Therapeutics, Inc. (NASDAQ:PTCT) to report earnings on March, 5. They expect $-0.41 earnings per share, down 1,466.67% or $0.44 from last year’s $0.03 per share. After $-0.94 actual earnings per share reported by PTC Therapeutics, Inc. for the previous quarter, Wall Street now forecasts -56.38% EPS growth.

PTC Therapeutics, Inc. (NASDAQ:PTCT) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.